LSBio
Monoclonal Mouse anti-Human FASN / Fatty Acid Synthase Antibody (clone 3F2-1F3, IF, WB)

FASN monoclonal antibody (M01), clone 3F2-1F3 Western blot of FASN expression in 293.

Monoclonal Mouse anti-Human FASN / Fatty Acid Synthase Antibody (clone 3F2-1F3, IF, WB)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general), Western Blot
Reactivity:Human
Format:Liquid
See all Human FASN / Fatty Acid Synthase antibodies →
$342.00each
Catalog Number: LS-C104946-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Fatty Acid Synthase antibody LS-C104946 is an unconjugated mouse monoclonal antibody to human Fatty Acid Synthase (FASN). Validated for ELISA, IF and WB. Cited in 1 publication.
Application
ELISA, IF, IHC, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
FASN | Fatty acid synthase | OA-519 | SDR27X1
Recommended Dilution: IF/ICC
10 ug/ml
UniProt Number
P49327
SwissProt
P49327

Target

Target
Human FASN / Fatty Acid Synthase
Antigen Species
Human
Gene Name
FASN

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
3F2-1F3
Isotype
IgG1
Light Chain
Kappa Light Chain

Immunogen

Immunogen
FASN (AAH07909, 1 aa ~ 440 aa) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Immunogen Type
Fusion Protein (e.g., GST, MBP tag)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.4
Concentration
0.25 mg/mL
Preservative
No
Purification Method
Protein A Affinity

Storage & Handling

Storage Conditions
Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma10 Department of Medicine, University of Rochester Medical Center, Rochester, NY, United States12 Bioinformatics Core, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States14 Harold Hamm Diabetes Center, The University of Oklahoma Health Sciences Center, Oklahoma, OK, United States16 Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Dur. Dashnamoorthy Ravi , Afshin Beheshti , Nasséra Abermil, Frederick Lansigan , William Kinlaw, Nirupa R Matthan, Maisarah Mokhtar, Frank C Passero Jr, Patrick Puliti , Kevin A David , Gregory G Dolnikowski, Xiaoyang Su , Ying Chen, Mahboubi Bijan, Rohan R Varshney, Baek Kim , Sandeep S Dave, Michael C Rudolph, Andrew M Evens. Frontiers in oncology. 2021 Oct;11:725137. PubMed: 34765544 PMC: PMC8576537

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.